Document is current
Any future updates will be listed below
-
Authors
Edge, Rhiannon
Matthews, Sam https://orcid.org/0009-0007-2979-8131
Ahani, Bahar
Aksyuk, Anastasia A. https://orcid.org/0000-0001-9778-3491
Clegg, Lindsay
Perez, John L.
Esser, Mark T.
Chang, Lee-Jah
Hirsch, Ian
Villafana, Tonya
Pura, John
Stepanov, Oleg
Streicher, Katie
White, Tom
Cohen, Taylor S.
Follmann, Dean https://orcid.org/0000-0003-4073-0393
Gilbert, Peter B. https://orcid.org/0000-0002-2662-9427
Seegobin, Seth
-
Funding
Funding for this research was provided by:
AstraZeneca (Not applicable)
- License Information
-
More Information
Article History
Received: 7 October 2024
Accepted: 3 September 2025
First Online: 14 October 2025
Competing interests
: R.E., B.A., A.A.A., L.C., M.T.E., L-J.C., I.H., T.V., J.L.P., J.P., O.S., K.S., T.W., T.S.C. and S.S. are employees of, and may hold stock in, AstraZeneca. S.M. is an employee of MMS Holdings Inc. P.B.G. is a member of the AstraZeneca Advisory Board through a contract to his institution. D.F. reports no conflicts.
